Interaction between heparin and cardiac troponin T and troponin I from patients after coronary bypass surgery

Clinical Biochemistry

Volumn 35, Issue 5, 2002, Pages 355-362

  Speth, Maria ^a   Seibold, Kerstin ^a   Katz, Norbert ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Cardiac marker; Coronary bypass surgery; Heparin affinity chromatography; Heparin treatment; Heparinase; Protamine; Serum plasma correlation; Troponin T and I

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HEPARIN LYASE; LIGAND; PROTAMINE; SEPHAROSE; TROPONIN I; TROPONIN T;

AFFINITY CHROMATOGRAPHY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG BLOOD LEVEL; DRUG EFFECT; ELUTION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IONIC STRENGTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; AGED; AMINO ACID SEQUENCE; ARTIFACT; BLOOD; CHEMISTRY; CORONARY ARTERY BYPASS GRAFT; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; POSTOPERATIVE PERIOD; PROTEIN BINDING;

AGED; AMINO ACID SEQUENCE; ANTICOAGULANTS; ARTIFACTS; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, AFFINITY; CORONARY ARTERY BYPASS; HEPARIN; HEPARIN LYASE; HUMANS; IMMUNOASSAY; LIGANDS; MOLECULAR SEQUENCE DATA; POSTOPERATIVE PERIOD; PROTEIN BINDING; SEPHAROSE; TROPONIN I; TROPONIN T;

EID: 0036629896     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00328-4     Document Type: Article

References (32)

1. Katus H.A., Rempis A., Neumann F.J., et al. Diagnostic efficiency of troponin T measurement in acute myocardial infarction. Circulation. 83:1991;902-912.
2. Christenson R.H., Azzazy H.M.E. Biochemical markers of the acute coronary syndromes. Clin Chem. 44:1998;1855-1864.
3. Wu A.H.B., Feng Y.J., Moore R., Apple F.S., McPearson P.H., Buechler K.F., Bodor G. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem. 44:1998;1198-1208.
4. Green G.B., Green S.F. Markers of myocardial injury in the evaluation of the emergency department patient with chest pain. Wu A.H.B., Cardiac markers. 1998;75-101 Humana Press, Totowa NJ.
5. Wu A.H.B., Feng Y.J., Contois J.H. Prognostic value of cardiac troponin I in patients with chest pain. Clin Chem. 42:1996;651-652.
6. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl M Med. 335:1996;1342-1349.
7. Olatidoye A.G., Wu A.H., Feng Y.J., Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta analysis comparing published studies. Am J Cardiol. 15:1998;1405-1410.
8. Hamm C.W., Braunwald E. A classification of unstable angina revisited. Circulation. 102:2000;118-122.
9. Heeschen C., Hamm C.W., Goldmann B.U., Deu A., Langenbrink L., White H.D. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. The Lancet. 354:1999;1757-1762.
10. Heeschen C., Deu A., Langenbrink L., Goldmann B.U., Hamm C.W. Analytical, and diagnostic performance of troponin assays in patients suspicious for acute coronary syndromes. Clin Biochem. 33:2000;359-368.
11. Bonatti J., Hangler H., Hörmann C., Mair J., Falksammer J., Mair P. Myocardial damage after minimal invasive coronary artery bypass grafting on the beating heart. Ann Thorac Surg. 66:1998;1093-1096.
12. Sandony V., Korber M., Albes G., Podtschaske V., Etgen T., Trosken T., Ravens U., Scheulen M.E. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 13:1998;57-65.
13. Godet G., Ben-Ayed S., Bernard M., Foglietti M.J., Giullosson J.J., Kieffer E., Coriat P. Cardiac troponin I cutoff values to predict postoperative cardiac complications after circulatory arrest and profound hypothermia. J Cardiothorac Vasc Anesth. 13:1999;272-275.
14. Braun S.L., Barankay A., Mazzitelli D. Plasma troponin T and troponin I after minimally invasive coronary bypass surgery. Clin Chem. 46:2000;279-281.
15. Katrukha A., Bereznikova A., Filatov V., Esakova T. Biochemical factors influencing measurement of cardiac troponin I in serum. Clin Chem Lab Med. 37:1999;1091-1095.
16. Gerhardt W., Nordin G., Herbert A.K., Burzell B.L., Isaksson A., Gustavsson E., et al. Toponin T and I assays show decreased concentrations in heparin plasma compared with serum lower recoveries in early than in late phase of myocardial injury. Clin Chem. 46:2000;817-821.
17. Stiegler H., Fischer Y., Vazquez-Jimenez J.F., Graf J., Filzmaier K., Fausten B., Janssens U., Gressner A., Kunz D. Lower cardiac Troponin T and I results in heparin-plasma than in serum. Clin Chem. 4:2000;1338-1344.
18. Passing H., Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Biochem. 21:1983;709-720.
19. Bland J.M., Altman D.G. Statistical methods for assessing the agreement between two methods of clinical measurement. Lancet. 1:1986;307-310.
20. Pollock M.A., Jefferson S.G., Kane J.W., Lomax K., MacKinnon G., Winnard C.B. Method comparison - a different approach. Ann Clin Biochem. 29:1992;556-560.
21. Data P., Foster K., Dasgupta A. Comparison of immunoreactivity of five human cardiac troponin I assays toward free and complexed forms of the antigen implications for assay discordance. Clin Chem. 45:1999;2266-2269.
22. Zot A.S., Potter J.D. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biophys Biophys Chem. 16:1987;235-305.
23. Mesnard L., Samson F., Espinasse I., Durand J., Mercadier J.J. Molecular cloning and developmental expression of troponin T. FEBS Lett. 328:1993;139-144.
24. Vallins W.J., Brand N.J., Dabhade N., Butler-Browne G., Yacoub M.H., Barton P.J. Molecular cloning of human cardiac troponin I using polymerase chain reaction. FEBS Lett. 270:1990;57-61.
25. Verrecchio A., Germann M.W., Schick B.P., Kung B., Twardowski T., San Antonio J.D. Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J Biol Chem. 275:2000;7701-7707.
26. Fromm J.R., Hileman R.E., Caldwell E.E., Weiler J.M., Linhardt R.J. Differences in the interaction of heparin with arginine, and lysine, and the importance of basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys. 10:1995;279-287.
27. Erdman J., Wischke S., Kallisch H., Riede R., Heidenreich M., Fleck E., Regitz-Zagrosek V. A novel missense ARG 278 PRO mutation in the troponin T gene. Hum Mutat. 12:1998;364.
28. Saba Z., Nassar R., Ungerleider R.M., Oakeley A.E., Anderson P.A.W. Cardiac troponinT isoform expression correlates with pathophysiological descriptors in patients who underwent corrective surgery for congenital heart disease. Circulation. 94:1996;472-476.
29. Morjana N.A. Degradation of human cardiac troponin I after myocardial infarction. Biotechnol Appl Biochem. 28:1998;105-111.
30. Torti S.V., Akimoto H., Lin K., Billingham M.E., Torti F.M. Selective inhibition of muscle gene expression by oxidative stress in cardiac cells. J Mol Cell Cardiol. 30:1998;1173-1180.
31. Sulkalke P.V., Vo X.T., Phan T.D., Morris T.E. Phosphorylation of the inhibitory sununit of troponin and phospholamban in rat cardiomyocytes modulation by exposure of cardiomyocytes to hydroxyl radicals and sulfhydryl group reagents. Mol Cell Biochem. 175:1997;98-107.
32. Wu A.H.B., Apple F.S., Gibler W.B., Jesse R.J., Warshaw M.M., Valders R. National Academy of Clinical Biochemistry Standards of Laboratory Practice recommendations for the use of cardiac markers in coronary artery disease. Clin Chem. 45:1999;1104-1121.